Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

March 01, 2014; Volume 348,Issue 3

Highlighted Papers

  • You have access
    Direct Vasodilatory Effect of GPBAR1 Agonists in Dog
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 359; DOI: https://doi.org/10.1124/jpet.114.0314HI
  • You have access
    Simvastin Exposure in Nonalcoholic Steatohepatitis
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 359; DOI: https://doi.org/10.1124/jpet.114.0314HIa
  • You have access
    MGM-16, a Novel Dual-Acting µ- and δ-Opioid Agonist
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 359; DOI: https://doi.org/10.1124/jpet.114.0314HIb
  • You have access
    Stimulant-Like Effects of Nicotinic Agonists
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 359; DOI: https://doi.org/10.1124/jpet.114.0314HIc

Behavioral Pharmacology

  • You have access
    Orally Active Opioid μ/δ Dual Agonist MGM-16, a Derivative of the Indole Alkaloid Mitragynine, Exhibits Potent Antiallodynic Effect on Neuropathic Pain in Mice
    Kenjiro Matsumoto, Minoru Narita, Naotaka Muramatsu, Terumi Nakayama, Kaori Misawa, Mariko Kitajima, Kimihito Tashima, Lakshmi A. Devi, Tsutomu Suzuki, Hiromitsu Takayama and Syunji Horie
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 383-392; DOI: https://doi.org/10.1124/jpet.113.208108
  • You have access
    Methamphetamine-Like Discriminative-Stimulus Effects of Nicotinic Agonists
    Rajeev I. Desai and Jack Bergman
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 478-488; DOI: https://doi.org/10.1124/jpet.113.211235

Cardiovascular

  • You have access
    G Protein–Coupled Bile Acid Receptor 1 Stimulation Mediates Arterial Vasodilation through a KCa1.1 (BKCa)–Dependent Mechanism
    Ryan M. Fryer, Khing Jow Ng, Suzanne G. Nodop Mazurek, Lori Patnaude, Donna J. Skow, Akalushi Muthukumarana, Kyle E. Gilpin, Roger M. Dinallo, Daniel Kuzmich, John Lord, Sulagna Sanyal, Hui Yu, Christian Harcken, Matthew A. Cerny, Eugene R. Hickey and Louise K. Modis
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 421-431; DOI: https://doi.org/10.1124/jpet.113.210005
  • You have access
    20-HETE Regulates the Angiogenic Functions of Human Endothelial Progenitor Cells and Contributes to Angiogenesis In Vivo
    Li Chen, Rachel Ackerman, Mohamed Saleh, Katherine H. Gotlinger, Michael Kessler, Lawrence G. Mendelowitz, John R. Falck, Ali S. Arbab, A. Guillermo Scicli, Michal L. Schwartzman, Jing Yang and Austin M. Guo
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 442-451; DOI: https://doi.org/10.1124/jpet.113.210120

Cellular and Molecular

  • You have access
    Rare Human Nicotinic Acetylcholine Receptor α4 Subunit (CHRNA4) Variants Affect Expression and Function of High-Affinity Nicotinic Acetylcholine Receptors
    T. D. McClure-Begley, R. L. Papke, K. L. Stone, C. Stokes, A. D. Levy, J. Gelernter, P. Xie, J. Lindstrom and M. R. Picciotto
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 410-420; DOI: https://doi.org/10.1124/jpet.113.209767

Chemotherapy, Antibiotics, and Gene Therapy

  • You have access
    Improved Apoptotic Cell Death in Drug-Resistant Non–Small-Cell Lung Cancer Cells by Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Based Treatment
    L. Gatti, G. Cossa, S. Tinelli, N. Carenini, N. Arrighetti, M. Pennati, D. Cominetti, M. De Cesare, F. Zunino, N. Zaffaroni and P. Perego
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 360-371; DOI: https://doi.org/10.1124/jpet.113.210054
  • You have access
    DW09849, a Selective Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Prevents PI3K Signaling and Preferentially Inhibits Proliferation of Cells Containing the Oncogenic Mutation p110α (H1047R)
    Jia-li Liu, Guo-rui Gao, Xi Zhang, Su-fen Cao, Chen-liang Guo, Xiang Wang, Lin-jiang Tong, Jian Ding, Wen-hu Duan and Ling-hua Meng
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 432-441; DOI: https://doi.org/10.1124/jpet.113.210724

Drug Discovery and Translational Medicine

  • You have access
    No Activation of Human Pregnane X Receptor by Hyperforin-Related Phloroglucinols
    Benjamin A. Kandel, Sean Ekins, Kristina Leuner, Wolfgang E. Thasler, Christian Harteneck and Ulrich M. Zanger
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 393-400; DOI: https://doi.org/10.1124/jpet.113.209916

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Anti-Inflammatory and Antinociceptive Action of an Orally Available Nociceptin Receptor Agonist SCH 221510 in a Mouse Model of Inflammatory Bowel Diseases
    Marta Sobczak, Anna Mokrowiecka, Adam I. Cygankiewicz, Piotr K. Zakrzewski, Maciej Sałaga, Martin Storr, Radzisław Kordek, Ewa Małecka-Panas, Wanda M. Krajewska and Jakub Fichna
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 401-409; DOI: https://doi.org/10.1124/jpet.113.209825

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression
    John D. Clarke, Rhiannon N. Hardwick, April D. Lake, Mark J. Canet and Nathan J. Cherrington
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 452-458; DOI: https://doi.org/10.1124/jpet.113.211284
  • You have access
    Sphingolipid Signaling Reduces Basal P-Glycoprotein Activity in Renal Proximal Tubule
    David S. Miller
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 459-464; DOI: https://doi.org/10.1124/jpet.113.210641
  • You have access
    Regulation of UDP-Glucuronosyltransferase 1A1 Expression and Activity by MicroRNA 491-3p
    Douglas F. Dluzen, Dongxiao Sun, Anna C. Salzberg, Nate Jones, Ryan T. Bushey, Gavin P. Robertson and Philip Lazarus
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 465-477; DOI: https://doi.org/10.1124/jpet.113.210658

Neuropharmacology

  • You have access
    AS1069562, the (+)-Isomer of Indeloxazine, Exerts Analgesic Effects in a Rat Model of Neuropathic Pain with Unique Characteristics in Spinal Monoamine Turnover
    Nobuhito Murai, Toshiaki Aoki, Seiji Tamura, Toshihiro Sekizawa, Shuichiro Kakimoto, Mina Tsukamoto, Tomoya Oe, Ryugo Enomoto, Nozomu Hamakawa and Nobuya Matsuoka
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 372-382; DOI: https://doi.org/10.1124/jpet.113.208686

Notice of Retraction

  • You have access
    Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545–552; doi:10.1124/jpet.105.087643
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 493; DOI: https://doi.org/10.1124/jpet.114.03er14b

Errata

  • You have access
    Correction to “Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia”
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 489; DOI: https://doi.org/10.1124/jpet.114.03er14
  • You have access
    Correction to “Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration”
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 490-491; DOI: https://doi.org/10.1124/jpet.114.03er14a
  • You have access
    Correction to “G Protein–Coupled Bile Acid Receptor 1 Stimulation Mediates Arterial Vasodilation through a KCa1.1 (BKCa)–Dependent Mechanism”
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 492; DOI: https://doi.org/10.1124/jpet.114.03er14c
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 348 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 348, Issue 3
1 Mar 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Highlighted Papers
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Notice of Retraction
  • Errata
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor
  • Nose-to-Brain Delivery
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics